Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 388.20
-20.40 (-4.99%)
Jan 23, 2026, 3:29 PM IST
Sakar Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 2,040 | 1,776 | 1,534 | 1,334 | 1,282 | 947.39 | Upgrade |
Other Revenue | 5.22 | 5.22 | 8.16 | 8.33 | 8.91 | 5.72 | Upgrade |
| 2,045 | 1,781 | 1,542 | 1,342 | 1,291 | 953.12 | Upgrade | |
Revenue Growth (YoY) | 23.91% | 15.53% | 14.89% | 3.93% | 35.47% | 13.58% | Upgrade |
Cost of Revenue | 968.13 | 824.14 | 842.09 | 737.45 | 748.77 | 514.6 | Upgrade |
Gross Profit | 1,077 | 956.93 | 699.59 | 604.47 | 542.41 | 438.52 | Upgrade |
Selling, General & Admin | 367.84 | 317.32 | 198.62 | 169.35 | 153.55 | 132.82 | Upgrade |
Other Operating Expenses | 184.26 | 133.66 | 106.73 | 94.1 | 85.81 | 73.86 | Upgrade |
Operating Expenses | 771.71 | 659.8 | 485.85 | 413.3 | 336.04 | 287.26 | Upgrade |
Operating Income | 304.93 | 297.13 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade |
Interest Expense | -85.24 | -78.97 | -67.45 | -54.88 | -25.88 | -23.34 | Upgrade |
Interest & Investment Income | 0.18 | 0.18 | 1.25 | 3.93 | 0.56 | 0.16 | Upgrade |
Currency Exchange Gain (Loss) | 7.4 | 7.4 | 17.23 | 34.49 | 11.62 | 5.85 | Upgrade |
Other Non Operating Income (Expenses) | 1.19 | -6.57 | -8.71 | -4.75 | -3.22 | -1.61 | Upgrade |
EBT Excluding Unusual Items | 228.47 | 219.18 | 156.06 | 169.96 | 189.46 | 132.33 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 2.94 | - | 0.62 | - | Upgrade |
Gain (Loss) on Sale of Assets | -3.39 | -3.39 | - | - | - | - | Upgrade |
Other Unusual Items | -0.51 | -0.51 | - | -0.05 | - | - | Upgrade |
Pretax Income | 224.56 | 215.27 | 159 | 169.91 | 190.08 | 132.33 | Upgrade |
Income Tax Expense | 29.51 | 40.25 | 42.29 | 42.33 | 37.65 | 25.5 | Upgrade |
Net Income | 195.05 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade |
Net Income to Common | 195.05 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade |
Net Income Growth | 57.26% | 49.96% | -8.53% | -16.30% | 42.69% | 11.01% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade |
Shares Change (YoY) | 6.33% | 6.20% | 11.49% | 23.33% | - | 0.77% | Upgrade |
EPS (Basic) | 8.84 | 7.97 | 5.64 | 6.86 | 10.11 | 7.09 | Upgrade |
EPS (Diluted) | 8.84 | 7.95 | 5.63 | 6.86 | 10.11 | 7.09 | Upgrade |
EPS Growth | 47.89% | 41.21% | -17.95% | -32.13% | 42.69% | 10.17% | Upgrade |
Free Cash Flow | -31.09 | 17.5 | -350.93 | -488.51 | -109.08 | -209.69 | Upgrade |
Free Cash Flow Per Share | -1.41 | 0.80 | -16.93 | -26.27 | -7.24 | -13.91 | Upgrade |
Gross Margin | 52.65% | 53.73% | 45.38% | 45.05% | 42.01% | 46.01% | Upgrade |
Operating Margin | 14.91% | 16.68% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade |
Profit Margin | 9.54% | 9.83% | 7.57% | 9.51% | 11.80% | 11.21% | Upgrade |
Free Cash Flow Margin | -1.52% | 0.98% | -22.76% | -36.40% | -8.45% | -22.00% | Upgrade |
EBITDA | 515.45 | 496.85 | 393.27 | 341.03 | 279.66 | 206.34 | Upgrade |
EBITDA Margin | 25.21% | 27.90% | 25.51% | 25.41% | 21.66% | 21.65% | Upgrade |
D&A For EBITDA | 210.52 | 199.72 | 179.54 | 149.86 | 73.28 | 55.08 | Upgrade |
EBIT | 304.93 | 297.13 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade |
EBIT Margin | 14.91% | 16.68% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade |
Effective Tax Rate | 13.14% | 18.70% | 26.60% | 24.91% | 19.81% | 19.27% | Upgrade |
Revenue as Reported | 2,060 | 1,789 | 1,565 | 1,380 | 1,304 | 959.15 | Upgrade |
Advertising Expenses | - | 0.07 | 0.07 | 0.28 | 0.22 | 0.06 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.